Inhibikase Therapeutics’ $10 Million Direct Offering and Private Placements - McDermott Will & Emery

Inhibikase Therapeutics’ $10 Million Direct Offering and Private Placements

Overview


McDermott is mentioned in Global Legal Chronicle for representing Inhibikase Therapeutics.

The deal team was led by Merrill Kraines and Todd Kornfeld and included Brian Malkin, Kishan Mistry, Mike Blane and Mike Kim.